Today it was reported that the CVP, Gen. Counsel & Secretary of Idexx Laboratories (NASDAQ: IDXX), Jacqueline Studer, exercised options to buy 1,785 IDXX shares at $79.52 a share, for a total transaction value of $142K.
Following this transaction Jacqueline Studer’s holding in the company was increased by 30.53% to a total of $1.87 million. In addition to Jacqueline Studer, one other IDXX executive reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
Based on Idexx Laboratories’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $581 million and quarterly net profit of $109 million. In comparison, last year the company earned revenue of $509 million and had a net profit of $85.36 million. IDXX’s market cap is $21.23B and the company has a P/E ratio of 70.70. Currently, Idexx Laboratories has an average volume of 281.2K.
Nine different firms, including Merrill Lynch and C.L. King, currently also have a Buy rating on the stock. Starting in June 2018, IDXX received 7 Buy ratings in a row. Based on 5 analyst ratings, the analyst consensus is Strong Buy with an average price target of $245.50, reflecting a -0.8% downside.
In the last 30 days, insiders have sold $2.08M worth of IDXX shares and purchased $242.4K worth of IDXX shares. The insider sentiment on Idexx Laboratories has been negative according to 53 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: Companion Animal Group; Water; Livestock, Poultry, and Dairy; and Other.
